Trial Profile
Phase I trial of ZY H7 for treating dyslipidaemia and metabolic disorders
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 30 Jun 2016
Price :
$35
*
At a glance
- Drugs ZY H7 (Primary)
- Indications Dyslipidaemias; Metabolic disorders
- Focus Adverse reactions
- 16 Apr 2010 New trial record